CCL5 and neoplasm: Various secreted factors associated with TAMs are also potential biomarkers, such as Tim-3 which correlates with increased tumour invasion and lymph node metastasis [20] and CCL5/RANTES and NFKB1 where SNPs are associated with altered clinical outcome [21].